Skip to content
← Back to this collection

PUBLICATIONS · 26282634

High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2015 Nov 20
First author
Ferreri AJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2015 Nov 20;33(33):3851-3. doi: 10.1200/JCO.2015.63.1143.
    note
    Source null
    related pmid
    26282665
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2016 May 20;34(15):1829-30. doi: 10.1200/JCO.2015.65.0879.
    note
    Source null
    related pmid
    27001566
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2016 May 20;34(15):1830-1. doi: 10.1200/JCO.2016.66.4722.
    note
    Source null
    related pmid
    27001567
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2016 May 20;34(15):1831-2. doi: 10.1200/JCO.2016.66.4730.
    note
    Source null
    related pmid
    27001575
    relationship
    Comment in

Authors and identifiers

  1. name
    Ferreri AJ
    type
    Author
  2. name
    Donadoni G
    type
    Author
  3. name
    Cabras MG
    type
    Author
  4. name
    Patti C
    type
    Author
  5. name
    Mian M
    type
    Author
  6. name
    Zambello R
    type
    Author
  7. name
    Tarella C
    type
    Author
  8. name
    Di Nicola M
    type
    Author
  9. name
    D'Arco AM
    type
    Author
  10. name
    Doa G
    type
    Author
  11. name
    Bruno-Ventre M
    type
    Author
  12. name
    Assanelli A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ferreri AJ
    type
    Author
  2. name
    Donadoni G
    type
    Author
  3. name
    Cabras MG
    type
    Author
  4. name
    Patti C
    type
    Author
  5. name
    Mian M
    type
    Author
  6. name
    Zambello R
    type
    Author
  7. name
    Tarella C
    type
    Author
  8. name
    Di Nicola M
    type
    Author
  9. name
    D'Arco AM
    type
    Author
  10. name
    Doa G
    type
    Author
  11. name
    Bruno-Ventre M
    type
    Author
  12. name
    Assanelli A
    type
    Author
bibliography ids
  1. nci-bib-8a7c43b2f976b4f7a5d90687
book metadata
content sha256
91a17563f5a98fd31fb6b652e7efbc2ed035deab0624850cdc17dcbc9c7f9b0c
document type
citation
dois
  1. 10.1200/JCO.2015.61.1236
electronic publication date
display
2015 Aug 17
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26282634
immutable id
pubmed:26282634@91a17563f5a98fd31fb6b652e7efbc2ed035deab0624850cdc17dcbc9c7f9b0c
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
33
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3903-10
volume
33
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2015 Nov 20;33(33):3851-3. doi: 10.1200/JCO.2015.63.1143.
    note
    Source null
    related pmid
    26282665
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2016 May 20;34(15):1829-30. doi: 10.1200/JCO.2015.65.0879.
    note
    Source null
    related pmid
    27001566
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2016 May 20;34(15):1830-1. doi: 10.1200/JCO.2016.66.4722.
    note
    Source null
    related pmid
    27001567
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2016 May 20;34(15):1831-2. doi: 10.1200/JCO.2016.66.4730.
    note
    Source null
    related pmid
    27001575
    relationship
    Comment in
outcomes validated
false
pmid
26282634
provenance
batch id
4c1ece5bfc3d8e2be622
provider
NCBI PubMed ESummary
record sha256
22d069b88d47a035314031b31c94eb98e581a0291c2627ff16212b9a840b1ca9
response sha256
85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
retrieved at
2026-09-09T23:47:12.730551+00:00
publication date
display
2015 Nov 20
precision
day
year
2015
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26282634/
title
High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial.

Preserved source evidence · Independent clinical review pending · Not medical advice